ZCA
IRWD icon

Zeke Capital Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Zeke Capital Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28,345
Closed -$357K – 509
2022
Q1 		$357K Buy
28,345
+5,621
+25% +$64.4K 0.02% 314
2021
Q4 		$265K Buy
22,724
+1,721
+8% +$21.1K 0.02% 248
2021
Q3 		$274K Buy
21,003
+1,740
+9% +$22.5K 0.02% 230
2021
Q2 		$248K Buy
19,263
+5,137
+36% +$58.8K 0.02% 267
2021
Q1 		$158K Hold
14,126
– – 0.01% 285
2020
Q4 		$161K Buy
+14,126
New +$155K 0.01% 276

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zeke Capital Advisors's IRWD Position: Q2 2022 in Review

Zeke Capital Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 28,345 shares — an estimated $357K sold.

Zeke Capital Advisors first reported a position in IRWD in Q4 2020 and held it in 6 quarters. The position peaked at $357K in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • Zeke Capital Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Zeke Capital Advisors sold 28,345 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $357K.
  • Zeke Capital Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Zeke Capital Advisors's Ironwood Pharmaceuticals position peaked at $357K in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Zeke Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.